Business Wire

B-MEDICAL-SYSTEMS

7.10.2021 13:23:11 CEST | Business Wire | Press release

Share
B Medical Systems Significantly Expands Manufacturing Capacity to Support COVID Vaccination Campaign Worldwide

B Medical Systems , a global leader in the vaccine cold chain, has significantly expanded its production capacity at its Luxembourg facility. The global roll-out of COVID-19 vaccines created an unprecedented demand for vaccine cold chain solutions and expansion of the production facility was necessary to meet the global demand. The new factory expansion of around 4,500 m2 was built in six months and will create around 150 additional jobs. The expansion will help the company double its production capacity for vaccine cold chain units and increase production capacity for Ultra-Low Freezers fivefold.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211007005554/en/

B Medical Systems’ ultra-low freezers, vaccine refrigerators/freezers, laboratory refrigerators/ freezers, and transport boxes can store and transport COVID-19 vaccines at various temperature profiles ranging from -80°C to 8°C. The company has provided more than 70,000 cold chain units to 140+ countries for their effective COVID-19 immunization programs. B Medical Systems is also the exclusive supplier of Luxembourg’s COVID-19 vaccine cold chain solution.

Especially for vaccinating people in hard-to-reach areas, B Medical Systems together with Toyota Tsusho Corporation (TTC) has developed the Refrigerated Vaccine Transport Vehicle (RVTV ). This is the very first refrigerated vehicle in the world to be PQS pre-qualified by the WHO and can be used to reliably transport vaccines or other specimens in a temperature range of 2-8°C. The vehicle will provide invaluable logistical support for the delivery of vaccines to regions where the Covid vaccine is being rolled out, including Africa and Latin America.

On this occasion, Mr. Luc Provost, CEO of B Medical Systems said, “Today is a major milestone for us. The production capacity expansion reflects our strong commitment to the world in ensuring reliable medical cold chain solutions with the shortest lead times. Our aim is to make Luxembourg, a global leader in the end-to-end medical cold chain industry, and this facility takes us one step closer to realizing this dream”

B Medical Systems also manufactures blood management solutions that are used by the clinical sector and blood /transfusion segment across the world. The company has 40+ years of experience in providing reliable cold chain solutions and works with humanitarian organizations like UNICEF, Red Cross, etc, ministries of health, hospitals, research institutes, pharmaceutical companies across the world. The company has regional subsidiaries in the United States and India.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Global EV Alliance Survey: EV Drivers Identify Myths and Misconceptions as the Biggest Barrier to Adoption17.11.2026 19:00:00 CET | Press release

Myths and misconceptions about electric cars, from battery lifespan and fire risk to grid collapse, are the biggest barrier to EV adoption, according to respondents to the annual Global EV Driver Survey. The 2026 survey draws on responses from more than 29,500 EV drivers across 34 countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261117539716/en/ MYTHS. Battery lifespan (72%), fire risk (58%) and grid collapse (45%) top the list of EV myths reported by respondents to the 2026 Global EV Driver Survey, which gathered responses from more than 29,500 EV drivers across 34 countries. “The EV transition is not just an infrastructure or affordability challenge. It is also an information challenge. Outdated information and misconceptions continue to influence decisions long after the technology has moved on,” says Ellen Hiep, from the Steering Committee of the Global EV Alliance (GEVA). Myths the greatest barrier Asked to ide

TreeFrog Therapeutics Appoints James Sterling as Chief Financial Officer17.11.2026 18:04:00 CET | Press release

Seasoned biotech CFO with gene therapy, diagnostics, IPO and Wall Street experience joins the executive leadership team TreeFrog Therapeutics, a biotechnology company developing scalable cell therapies built on its proprietary C-Stem™ technology, today announced the appointment of James Sterling as Chief Financial Officer, effective November 1, 2026. James joins TreeFrog’s executive leadership team and reports to Mark Rothera, President and Chief Executive Officer. He oversees finance, investor relations and corporate development as the company enters its next phase of growth. “I am delighted to welcome James to TreeFrog. James brings a valuable combination of biotech CFO and Wall Street experience that supports our ambitions to develop TreeFrog into a key enabling partner and drug developer in the regenerative medicines field,” said Mark Rothera, President and Chief Executive Officer of TreeFrog Therapeutics. James contributes deep experience in corporate finance, capital markets and

Visa Report: AI-Enabled Fraud and Third-Party Attacks Are Scaling Worldwide17.11.2026 16:40:00 CET | Press release

Third-party incidents surged 62%, while Visa Scam Disruption identified more than $1.4 billion in potential fraud Fraud is becoming more automated, targeted and global as criminals use AI to exploit weak points across the payments ecosystem and target third-party providers that can provide access to multiple downstream payment organizations, according to the Visa (NYSE: V) Fall 2026 Biannual Threats Report released today during International Fraud Awareness Week. Developed by Visa Payment Ecosystem Risk and Control (PERC), the report examines threat activity observed between January and June 2026 and finds that AI is not creating entirely new categories of fraud. Instead, it is helping criminals that execute existing attacks faster, at greater scale, and with greater precision, while increasingly targeting third-party providers that can provide access to multiple downstream organizations at once. Although attack volumes increased in several areas, the report also found evidence that co

Sparxity Appoints former Cray CEO Peter Ungaro and Semiconductor Veteran Daniel Armbrust to its Advisory Board17.11.2026 16:00:00 CET | Press release

Appointments bring decades of leadership experience in supercomputing, semiconductor commercialization, and scaling advanced computing business Sparxity, a leader in sparse-native computing, today announced that Peter Ungaro, former President and CEO of Cray, Inc., and Daniel Armbrust, former President and CEO of SEMATECH and co-founder of Silicon Catalyst, have joined its Advisory Board as independent members. Armbrust has been elected Chairman of the Advisory Board and Ungaro Deputy Chairman by their fellow board members. The appointments strengthen the company’s leadership as it scales its sparse-native computing technology for next-generation AI and high-performance computing (HPC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261117761685/en/ From left to right, Daniel Armbrust, former President and CEO of SEMATECH and co-founder of Silicon Catalyst and Peter Ungaro, former President and CEO of Cray, Inc. Peter Ungaro

SES to Develop European Direct-to-Device Technologies under ESA Partnership Project17.11.2026 15:30:00 CET | Press release

The new SELYCE programme supports transition towards hybrid networks to strengthen Europe’s critical communications infrastructures SES today announced it will lead the industrial activities of SELYCE, a new European initiative focused on developing the technologies needed to enable future Direct-to-Device (D2D) satellite services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261117544892/en/ SES to Develop European Direct-to-Device Technologies under ESA Partnership Project Conducted under a Partnership Project with the European Space Agency (ESA) and supported by the Luxembourg Space Agency (LSA), Belgian Science Policy Office (BELSPO) and UK Space Agency (UKSA), SELYCE brings together European industry and research organisations to advance standards-based 5G Non-Terrestrial Network (NTN) capabilities that will allow everyday smartphones and IoT devices to connect seamlessly via satellite beyond the reach of terrestrial

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye